pyruvaldehyde has been researched along with Myocardial Ischemia in 2 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyridoxamine treatment decreased glycation and restored the activation of JNK and Akt during ischemia." | 1.39 | Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia. ( Almeida, F; Crisóstomo, J; Gonçalves, L; Matafome, P; Rodrigues, T; Santos-Silva, D; Seiça, R; Sena, C, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crisóstomo, J | 2 |
| Matafome, P | 2 |
| Santos-Silva, D | 2 |
| Rodrigues, L | 1 |
| Sena, CM | 1 |
| Pereira, P | 1 |
| Seiça, R | 2 |
| Almeida, F | 1 |
| Rodrigues, T | 1 |
| Sena, C | 1 |
| Gonçalves, L | 1 |
2 other studies available for pyruvaldehyde and Myocardial Ischemia
| Article | Year |
|---|---|
Methylglyoxal chronic administration promotes diabetes-like cardiac ischaemia disease in Wistar normal rats.
Topics: Animals; Apoptosis; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Heart; Male; Myocar | 2013 |
Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Survival; Glycation End Products, Advanced; JNK | 2013 |